203 related articles for article (PubMed ID: 24395328)
1. Newborn screening for fragile X syndrome.
Tassone F
JAMA Neurol; 2014 Mar; 71(3):355-9. PubMed ID: 24395328
[TBL] [Abstract][Full Text] [Related]
2. An assessment of screening strategies for fragile X syndrome in the UK.
Pembrey ME; Barnicoat AJ; Carmichael B; Bobrow M; Turner G
Health Technol Assess; 2001; 5(7):1-95. PubMed ID: 11262423
[TBL] [Abstract][Full Text] [Related]
3. Ethical, legal, and social concerns about expanded newborn screening: fragile X syndrome as a prototype for emerging issues.
Bailey DB; Skinner D; Davis AM; Whitmarsh I; Powell C
Pediatrics; 2008 Mar; 121(3):e693-704. PubMed ID: 18310190
[TBL] [Abstract][Full Text] [Related]
4. Refining reproductive risk for FMR1 premutation carriers in the general obstetric population.
Owens KM; Terhaar C; Zdrodowski J; Johnson LR; Eveleigh D
Am J Med Genet A; 2022 May; 188(5):1476-1481. PubMed ID: 35129870
[TBL] [Abstract][Full Text] [Related]
5. Population-based carrier screening and prenatal diagnosis of fragile X syndrome in East Asian populations.
Guo Q; Chang YY; Huang CH; Hsiao YS; Hsiao YC; Chiu IF; Zhou Y; Zhang H; Ko TM
J Genet Genomics; 2021 Dec; 48(12):1104-1110. PubMed ID: 34412977
[TBL] [Abstract][Full Text] [Related]
6. Assessing the Fragile X Syndrome Newborn Screening Landscape.
Riley C; Wheeler A
Pediatrics; 2017 Jun; 139(Suppl 3):S207-S215. PubMed ID: 28814541
[TBL] [Abstract][Full Text] [Related]
7. Molecular screening for fragile X syndrome in Thailand.
Limprasert P; Ruangdaraganon N; Sura T; Vasiknanonte P; Jinorose U
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():114-8. PubMed ID: 11400746
[TBL] [Abstract][Full Text] [Related]
8. Implications of the
Wheeler A; Raspa M; Hagerman R; Mailick M; Riley C
Pediatrics; 2017 Jun; 139(Suppl 3):S172-S182. PubMed ID: 28814538
[TBL] [Abstract][Full Text] [Related]
9. Newborn screening and cascade testing for FMR1 mutations.
Sorensen PL; Gane LW; Yarborough M; Hagerman RJ; Tassone F
Am J Med Genet A; 2013 Jan; 161A(1):59-69. PubMed ID: 23239591
[TBL] [Abstract][Full Text] [Related]
10. Fragile X Newborn Screening: Lessons Learned From a Multisite Screening Study.
Bailey DB; Berry-Kravis E; Gane LW; Guarda S; Hagerman R; Powell CM; Tassone F; Wheeler A
Pediatrics; 2017 Jun; 139(Suppl 3):S216-S225. PubMed ID: 28814542
[TBL] [Abstract][Full Text] [Related]
11. Maternal attitudes to newborn screening for fragile X syndrome.
Christie L; Wotton T; Bennetts B; Wiley V; Wilcken B; Rogers C; Boyle J; Turner C; Hansen J; Hunter M; Goel H; Field M
Am J Med Genet A; 2013 Feb; 161A(2):301-11. PubMed ID: 23303663
[TBL] [Abstract][Full Text] [Related]
12. Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA.
Coffee B; Keith K; Albizua I; Malone T; Mowrey J; Sherman SL; Warren ST
Am J Hum Genet; 2009 Oct; 85(4):503-14. PubMed ID: 19804849
[TBL] [Abstract][Full Text] [Related]
13. Maternal FMR1 alleles expansion in newborns during transmission: a prospective cohort study.
Shahid R; Yasin M; Rehman ZU; Jadoon H; Tahir H; Meraj N; Khan N; Zubair M; Zulfiqar I; Nowshid M; Azeem A; Jabeen M; Hameed A; Saleha S
Pediatr Res; 2023 Feb; 93(3):720-724. PubMed ID: 35681093
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of blood spot PCR in large-scale screening of fragile X syndrome in southern Taiwan.
Chow JC; Chen DJ; Lin CN; Chiu CY; Huang CB; Chiu PC; Lin CH; Lin SJ; Tzeng CC
J Formos Med Assoc; 2003 Jan; 102(1):12-6. PubMed ID: 12684606
[TBL] [Abstract][Full Text] [Related]
15. An effective strategy of using molecular testing to screen mentally retarded individuals for fragile X syndrome.
Tzeng CC; Lin SJ; Chen YJ; Kuo PL; Jong YJ; Tsai LP; Chen RM
Diagn Mol Pathol; 2001 Mar; 10(1):34-40. PubMed ID: 11277393
[TBL] [Abstract][Full Text] [Related]
16. Prenatal carrier testing for fragile X: counseling issues and challenges.
Musci TJ; Moyer K
Obstet Gynecol Clin North Am; 2010 Mar; 37(1):61-70, Table of Contents. PubMed ID: 20494258
[TBL] [Abstract][Full Text] [Related]
17. FMR1 allele frequencies in 51,000 newborns: a large-scale population study in China.
Zhang JY; Wu DW; Yang RL; Zhu L; Jiang MY; Wang WJ; Li XK; Jiang XL; Tong F; Shu Q
World J Pediatr; 2021 Dec; 17(6):653-658. PubMed ID: 34738199
[TBL] [Abstract][Full Text] [Related]
18. FMR1 premutation frequency in a large, ethnically diverse population referred for carrier testing.
Owens KM; Dohany L; Holland C; DaRe J; Mann T; Settler C; Longman RE
Am J Med Genet A; 2018 Jun; 176(6):1304-1308. PubMed ID: 29603880
[TBL] [Abstract][Full Text] [Related]
19. Cascade Testing for Fragile X Syndrome in a Rural Setting in Cameroon (Sub-Saharan Africa).
Kengne Kamga K; Nguefack S; Minka K; Wonkam Tingang E; Esterhuizen A; Nchangwi Munung S; De Vries J; Wonkam A
Genes (Basel); 2020 Jan; 11(2):. PubMed ID: 32012997
[TBL] [Abstract][Full Text] [Related]
20. Parent perspectives following newborn screening resulting in diagnoses of fragile X syndrome or fragile X premutation.
Corbo A; Tzeng JP; Scott S; Cheves E; Cope H; Peay H
Res Dev Disabil; 2024 May; 148():104719. PubMed ID: 38507982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
